Fundraising FoxKevin Lind
InvestorVice President, Finance & Administration at Volta · Board Director at Avalo Therapeutics
Greater Boston
Find your path to Kevin
35 people in our graph can introduce you to Kevin.
Sign up to see every warm intro you have to Kevin
- Paths you didn't know you had: your email and LinkedIn already hold routes to Kevin. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Kevin Lind is a biotechnology executive with more than 20 years of leadership experience who led Longboard Pharmaceuticals through its $2.6 billion acquisition by Lundbeck. He was previously EVP and CFO at Arena Pharmaceuticals and chairs the board of Apnimed.
Colleagues at Volta
Amy Conrad
Senior Events Manager at Volta Labs
Andy Farnsworth
Director, SME AI Productivity Lab at Volta Labs
Bader Shaheen
Operations Coordinator at Volta
Christian MacNamara
AI Productivity Lab Program Lead at Volta
Kathleen Cohen
Senior Vice President, Clinical Development Operations at Avalo Therapeutics
Laura Simpson
Director of Community Experience at Volta Labs
Laurie Vaughan
Vice President, Finance + Administration at Volta Labs
Matt Cooper
Chief Executive Officer at Volta Labs
Frequently asked questions
- Who is Kevin Lind?
- Kevin Lind is a biotechnology executive with more than 20 years of leadership experience who led Longboard Pharmaceuticals through its $2.6 billion acquisition by Lundbeck. He was previously EVP and CFO at Arena Pharmaceuticals and chairs the board of Apnimed.
- Where does Kevin Lind work?
- Kevin Lind is Vice President, Finance & Administration at Volta and Board Director at Avalo Therapeutics.